Drugmaker Gilead Sciences plans to announce on Tuesday that it will provide up to $5 million in grants to help a coalition of LGBTQ+ and human rights advocacy groups craft public health responses to monkeypox outbreaks, the company said.
https://www.pharmalive.com/wp-content/uploads/2021/05/Russian-court-rejects-U.S-firms-lawsuit-over-COVID-19-drug-remdesivir-Reuters-5-27-21.jpg503960Reuters Healthhttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngReuters Health2022-08-09 10:28:132022-08-09 12:35:30Drugmaker Gilead to help fund monkeypox education for LGBTQ+ groups